NO893021L - Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228. - Google Patents

Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.

Info

Publication number
NO893021L
NO893021L NO89893021A NO893021A NO893021L NO 893021 L NO893021 L NO 893021L NO 89893021 A NO89893021 A NO 89893021A NO 893021 A NO893021 A NO 893021A NO 893021 L NO893021 L NO 893021L
Authority
NO
Norway
Prior art keywords
substance
preparing
procedure
active compound
biological active
Prior art date
Application number
NO89893021A
Other languages
English (en)
Norwegian (no)
Other versions
NO893021D0 (no
Inventor
Masakuni Okuhara
Toshio Goto
Yasuhiro Hori
Takashi Fujita
Hirotsugu Ueda
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10641100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO893021(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO893021D0 publication Critical patent/NO893021D0/no
Publication of NO893021L publication Critical patent/NO893021L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Reinforced Plastic Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO89893021A 1988-07-26 1989-07-25 Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228. NO893021L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817743A GB8817743D0 (en) 1988-07-26 1988-07-26 Fr901228 substance & preparation thereof

Publications (2)

Publication Number Publication Date
NO893021D0 NO893021D0 (no) 1989-07-25
NO893021L true NO893021L (no) 1990-01-29

Family

ID=10641100

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893021A NO893021L (no) 1988-07-26 1989-07-25 Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.

Country Status (16)

Country Link
US (1) US4977138A (da)
EP (1) EP0352646B1 (da)
JP (1) JPH0764872B2 (da)
CN (1) CN1040054A (da)
AT (1) ATE94561T1 (da)
AU (1) AU3829089A (da)
CA (1) CA1335083C (da)
DE (1) DE68909139T2 (da)
DK (1) DK366889A (da)
ES (1) ES2058411T3 (da)
FI (1) FI893359A (da)
GB (1) GB8817743D0 (da)
HU (1) HU211514A9 (da)
IL (1) IL90949A0 (da)
NO (1) NO893021L (da)
ZA (1) ZA895121B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130414A (en) * 1989-11-30 1992-07-14 Arizona Board Of Regents, A Body Corporate Of Arizona State University Isolation and structural elucidation of the cyclic peptide hymenistatin 1
JPH06247964A (ja) * 1993-02-22 1994-09-06 Snow Brand Milk Prod Co Ltd 新規生理活性物質ｈｓ−１及びその製造方法
CA2272554C (en) * 1996-11-22 2001-08-28 Pioneer Hi-Bred International, Inc. Moniliformin detoxification compositions and methods
DK1142905T3 (da) * 1999-01-13 2006-09-18 Astellas Pharma Inc Hidtil ukendt depsipeptidforbindelse
US6828302B1 (en) 1999-12-08 2004-12-07 Xcyte Therapies, Inc. Therapeutic uses of depsipeptides and congeners thereof
CA2393682C (en) 1999-12-08 2012-01-31 Xcyte Therapies, Inc. Depsipeptide and congeners thereof for use as immunosuppressants
JP4810784B2 (ja) * 2000-07-17 2011-11-09 アステラス製薬株式会社 還元型ｆｋ２２８およびその用途
WO2002020817A1 (en) 2000-09-01 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. A method of producing fr901228
PL210794B1 (pl) * 2001-08-21 2012-03-30 Astellas Pharma Inc Zastosowanie inhibitora deacetylazy histonowej FK228 lub jego soli
US20040132643A1 (en) * 2002-01-09 2004-07-08 Fojo Antonio Tito Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms
MXPA04009761A (es) * 2002-04-05 2005-05-27 Fujisawa Pharmaceutical Co Dipsipeptido para terapia de cancer renal.
JPWO2004074478A1 (ja) * 2003-02-19 2006-06-01 アステラス製薬株式会社 ヒストンデアセチラーゼ阻害剤の抗腫瘍効果の予測方法
EP2238982B8 (en) * 2003-06-27 2013-01-16 Astellas Pharma Inc. Therapeutic agent for soft tissue sarcoma
ES2425083T3 (es) 2003-09-25 2013-10-11 Astellas Pharma Inc. Agente antitumoral que comprende FK228 como inhibidor de histona desacetilasa y doxorrubicina como inhibidor de topoisomerasa II
EP1713460A2 (en) * 2003-12-10 2006-10-25 Wisconsin Alumni Research Foundation Fk228 analogs and their use as hdac-inhibitors
US7951780B2 (en) * 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
US20050187148A1 (en) * 2004-02-25 2005-08-25 Yoshinori Naoe Antitumor agent
US20050261174A1 (en) * 2004-05-20 2005-11-24 Paul Lewer Insecticidal activity of a cyclic peptide
WO2006055621A2 (en) * 2004-11-17 2006-05-26 The University Of Chicago Histone deacetylase inhibitors and methods of use
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
EP1965824A4 (en) * 2005-11-18 2011-10-19 Gloucester Pharmaceuticals Inc METABOLITENE DERIVATIVES OF HDAC INHIBITOR FK228
US20100137239A1 (en) * 2006-04-24 2010-06-03 Gloucester Pharmaceuticals Gemcitabine combination therapy
WO2007146730A2 (en) 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Deacetylase inhibitor therapy
CN101801994A (zh) * 2006-12-29 2010-08-11 格洛斯特制药公司 制备Romidepsin
BRPI0720734A2 (pt) * 2006-12-29 2014-01-07 Gloucester Pharmaceuticals Inc Preparação da romidepsina
WO2008098199A2 (en) * 2007-02-08 2008-08-14 Uwm Research Foundation, Inc. Sequences for fk228 biosyntnesis and methods of synthesizing fk228 and fk228 analogs
US20110060021A1 (en) * 2009-08-19 2011-03-10 Yiqiang Cheng Histone deacetylase inhibitors and uses thereof
AR080234A1 (es) * 2010-02-25 2012-03-21 Marrone Bio Innovations Inc Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
US20120190817A2 (en) 2010-07-12 2012-07-26 Celgene Corporation Romidepsin solid forms and uses thereof
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
KR20160054627A (ko) * 2011-08-27 2016-05-16 마론 바이오 이노베이션스, 인코포레이티드 부르크홀데리아 속의 단리된 박테리아 균주 및 그로부터의 살충 대사물-제제 및 용도
JP2014526558A (ja) 2011-09-23 2014-10-06 セルジーン コーポレイション リンパ腫の治療に使用するためのロミデプシン及び５−アザシチジン
AU2012316266B2 (en) 2011-09-26 2015-07-30 Celgene Corporation Combination therapy for chemoresistant cancers
JP6214397B2 (ja) 2011-09-30 2017-10-18 国立大学法人東北大学 新規ホスファチジルイノシトール３キナーゼ阻害剤及び医薬組成物
WO2013085902A1 (en) 2011-12-05 2013-06-13 The University Of Texas M.D. Combination therapy methods for treating an inflammatory breast cancer
AU2013201937B8 (en) * 2012-01-12 2015-08-20 Celgene Corporation Romidepsin formulations and uses thereof
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
CN103877010B (zh) * 2012-12-21 2018-06-01 正大天晴药业集团股份有限公司 一种罗米地辛溶液的制备方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
CN105026369A (zh) 2013-02-28 2015-11-04 德米拉股份有限公司 格隆铵盐
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
CN103173390B (zh) * 2013-03-16 2014-09-10 浙江海正药业股份有限公司 一种紫色杆菌菌株及其应用
CN104072589B (zh) * 2013-03-29 2017-09-22 浙江海正药业股份有限公司 抗肿瘤三硫化合物及其制备方法与应用
CN104450837B (zh) * 2013-09-18 2019-01-01 上海医药工业研究院 一种用于生产罗米地辛的方法及发酵培养基
CN104447950A (zh) * 2013-09-18 2015-03-25 上海医药工业研究院 一种罗米地辛的分离纯化方法
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
WO2015136548A2 (en) * 2014-03-04 2015-09-17 Concord Biotech Limited A process for isolation of romidepsin from fermentation broth and preparation of crystals of romidepsin
CN104894195B (zh) * 2014-03-07 2018-11-13 上海医药工业研究院 一种提高fk228产量的发酵培养基
CN104262456B (zh) * 2014-09-11 2018-01-09 浙江海正药业股份有限公司 一种罗米地辛的新晶型及其制备方法和用途
WO2016210292A1 (en) 2015-06-25 2016-12-29 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
WO2017068596A1 (en) * 2015-10-20 2017-04-27 Msn Laboratories Private Limited An improved process for the preparation of (1s, 4s, 7z, 10s, 16e, 21r)- 7-ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5, 8, 20, 23- tetraazabicyclo[8.7.6]tricos-16-ene-3, 6, 9, 19, 22-pentone
AU2017235461B2 (en) 2016-03-15 2023-02-23 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
EP3893647A1 (en) 2018-12-14 2021-10-20 Pioneer Hi-Bred International, Inc. Biologicals and their use in plants
US20220049213A1 (en) * 2018-12-24 2022-02-17 Marrone Bio Innovations, Inc. A method for increasing romidepsin production from fermentation broth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61101501A (ja) * 1984-10-24 1986-05-20 Yamanouchi Pharmaceut Co Ltd 制癌作用を有する多糖及びその製法
WO1986006065A1 (en) * 1985-04-18 1986-10-23 Pfizer Inc. Transformation product of thiosporamicin
DE3782199T2 (de) * 1986-07-08 1993-02-25 Takeda Chemical Industries Ltd Biologisch aktive peptide tan-866.
US4777160A (en) * 1986-09-18 1988-10-11 Bristol-Myers BU-2867T peptide antibiotics

Also Published As

Publication number Publication date
ZA895121B (en) 1990-08-29
FI893359A0 (fi) 1989-07-11
DK366889D0 (da) 1989-07-25
JPH0764872B2 (ja) 1995-07-12
NO893021D0 (no) 1989-07-25
US4977138A (en) 1990-12-11
AU3829089A (en) 1990-02-01
EP0352646B1 (en) 1993-09-15
EP0352646A2 (en) 1990-01-31
ES2058411T3 (es) 1994-11-01
IL90949A0 (en) 1990-02-09
FI893359A (fi) 1990-01-27
HU211514A9 (en) 1995-11-28
JPH0285296A (ja) 1990-03-26
CA1335083C (en) 1995-04-04
EP0352646A3 (en) 1990-10-31
GB8817743D0 (en) 1988-09-01
CN1040054A (zh) 1990-02-28
DK366889A (da) 1990-01-27
DE68909139T2 (de) 1994-02-10
ATE94561T1 (de) 1993-10-15
DE68909139D1 (de) 1993-10-21

Similar Documents

Publication Publication Date Title
NO893021L (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
ES466791A1 (es) Procedimiento para la produccion de esterastina.
JPS5492909A (en) New aminosaccharide and its preparation
JPS56128774A (en) New physiologically active substance ebelactone and its preparation
JPS56102793A (en) Preparation of antibiotic c-15003 p-3
ES8302090A1 (es) Un procedimiento para la preparacion del nuevo antibiotico bmo162-af2, obtenido mediante el cultivo de una cepa perte- neciente al genero bacillus.
JPS6438049A (en) Antimicrobial agent for human or animal
IE37331L (en) Production of saccharase inhibitor
GB1523835A (en) Process for maximising the growth and nicotine degrading activity of microorganismus
ES445965A1 (es) Procedimiento para la obtencion de nuevo antibiotico papula-candina.
JPS52114092A (en) Preparation of l-arginine by fermentation process
ES452021A1 (es) Un procedimiento para la produccion de la mezcla antibioticaa-30912.
ATE58142T1 (de) Valiolaminderivate und ihre herstellung.
JPS57139080A (en) 14,15-epoxy derivative of antibiotic substance b-41 and its preparation
JPS6040837B2 (ja) 抗生物質チオストレプトンの製造法
EP0659759A4 (da)
JPS6429378A (en) Physiologically active substance and production thereof
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
JPS5743697A (en) Improved preparation of antibiotic
JPS5459393A (en) Optical resolution of n-chloroacetyl-m-hydroxy-dl-phenyl- glycine
JPS5783281A (en) Novel fungus
JPS5426395A (en) Preparation of lactic acid dehydrogenase
JPS53113093A (en) Preparation of physiological active agent p9-12
JPS6429379A (en) Physiologically active substance and production thereof
DE1074826B (de) Verfahren zur Steigerung der Ausbeute von Antibiotika der Tetrazykhnreihe